Timing of operation in asymptomatic severe aortic stenosis

Hari P Chaliki1, Morgan L Brown, Thoralf M Sundt

  • 1Mayo Clinic Arizona, Division of Cardiovascular Diseases, 13400 E. Shea Boulevard, Scottsdale, AZ 85255, USA. chaliki.hari@mayo.edu

Insights

Calcific aortic stenosis is the leading cause of aortic stenosis, often managed with surgery for symptomatic patients. Early surgery may benefit select asymptomatic individuals with severe stenosis.

Area of Science:

  • Cardiology
  • Valvular Heart Disease

Background:

  • Calcific aortic stenosis (CAS) is now the primary cause of aortic stenosis, surpassing rheumatic fever.
  • Hyperlipidemia is a significant risk factor contributing to the progression of CAS.

Purpose of the Study:

  • To review the current understanding and management of calcific aortic stenosis.
  • To identify patient subgroups who may benefit from early surgical intervention.

Main Methods:

  • Review of current American College of Cardiology/American Heart Association guidelines for severe aortic stenosis.
  • Analysis of factors indicating severity: peak velocity > 4 m/sec, mean gradient > 40 mmHg, valve area < 1.0 cm(2).
  • Evaluation of indicators for early surgery in asymptomatic patients, including aortic valve calcium and exercise testing.

Main Results:

  • Severe aortic stenosis is defined by specific hemodynamic criteria.
  • Symptomatic patients with severe aortic stenosis have a poor prognosis without timely aortic valve surgery.
  • Asymptomatic patients with high aortic valve calcium or positive exercise tests may benefit from early surgery.

Conclusions:

  • Aortic valve surgery offers low risk and improved outcomes for selected asymptomatic patients with severe CAS due to advancements in techniques and prosthetics.
  • Percutaneous aortic valves are currently indicated for very high-risk symptomatic patients, with potential for expanded use.
  • Future molecular cardiology advancements may offer novel preventative therapies for CAS.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...